Bliss Gvs Pharma Ltd Financials: Profit & Loss Statement

Profit and loss statement
Balance sheet
Quarterly Result
Ratio

Profit and loss statement

CAGR in 10 years

Sales

7.61^%

Operating Profit

-0.30^%

PAT

-1.87^%

	Mar 2024 (Cr.)	Mar 2023 (Cr.)	Mar 2022 (Cr.)	Mar 2021 (Cr.)
SALES	605.46	598.34	636.36	465.51
OPERATING PROFIT	66.09	90.16	109.20	91.46
OP PROFIT MARGIN	10.92	15.07	17.16	19.65
INTEREST	5.81	10.06	4.32	4.19
PROFIT AFTER TAX	50.64	85.48	92.66	67.50
CASH PROFIT	74.97	121.38	112.70	83.64
EPS	4.84	8.21	8.94	6.54

Balance sheet

CAGR in 10 years

Net Worth

11.60^%

Debt

-1.62^%

Gross Block

14.80^%

	Mar 2024 (Cr.)	Mar 2023 (Cr.)	Mar 2022 (Cr.)	Mar 2021 (Cr.)	Mar 2020 (Cr.)
EQUITY	10.47	10.42	10.37	10.31	10.31
RESERVE SURPLUS	977.94	926.58	841.06	745.33	672.63
TOT DEBTS	77.50	80.57	89.91	91.84	93.09
GROSS BLOCK	414.15	385.72	270.23	211.63	203.03
CAPITAL WORK IN PROGRESS	7.83	2.80	22.15	2.39	0
CASH LIQUID INVESTMENT	169.32	84.61	149.48	119.52	86.62
NET WORKING CAPITAL	692.96	610.14	654.20	581.01	566.01
CURRENT ASSETS	797.30	743.29	796.75	680.24	646.22
CURRENT LIABILITIES	104.34	133.15	142.55	99.23	80.22

Quarterly Result

	Dec 2024 (Cr.)	Sep 2024 (Cr.)	Jun 2024 (Cr.)	Mar 2024 (Cr.)	Dec 2023 (Cr.)
SALES	179.59	182.65	148.96	163.82	161.33
GROSS PROFIT	36.73	30.29	32.41	-9	34.77
GROSS PROFIT MARGINS	50.90	49.95	38.84	52.08	50.04
OPERATING PROFIT	25.74	25.38	26.74	-15.93	28.66
OP PROFIT MARGIN	16.95	14.97	18.34	-8.36	18.79
INTEREST	0.67	3.45	1.17	1.53	1.79
PROFIT AFTER TAX	21.05	17.04	19.42	-11.46	20.72
CASH PROFIT	28.01	23.43	25.68	-5.23	26.97
EPS	2	1.63	1.85	-1.11	1.99

Ratio

CAGR in 10 years

Net Worth

11.60^%

Debt

-1.62^%

Gross Block

14.80^%

	Mar 2024 (%)	Mar 2023 (%)	Mar 2022 (%)	Mar 2021 (%)	Mar 2020 (%)
PE	23.29	8.68	8.61	15.08	11.26
P BV	1.19	0.79	0.94	1.35	1.52
MCAP SALES	1.95	1.24	1.25	2.19	2.35
ASSET TURNOVER	0.58	0.61	0.71	0.57	0.61
EV/EBITDA	10.92	5.24	5.11	9.07	7.63
DEBT/EQUITY	0.08	0.10	0.11	0.13	0.13
ROE	7.91	9.56	11.53	9.38	14.36
ROCE	11.19	12.81	14.59	11.71	17.64